Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × anifrolumab × 30 days × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

Specimen Handling 190 pembrolizumab 156 Magnetic Resonance Spectroscopy 151 Biopsy 114 Carboplatin 107 Cisplatin 89 Cyclophosphamide 81 Paclitaxel 72 venetoclax 67 Bevacizumab 66 Gemcitabine 62 Nivolumab 59 Radiotherapy 52 Dexamethasone 50 Rituximab 48 Pemetrexed 46 fludarabine 43 Oxaliplatin 43 Fluorouracil 42 Doxorubicin 37 Docetaxel 37 Capecitabine 36 atezolizumab 35 Cetuximab 34 Leucovorin 33 X-Rays 32 Prednisone 32 Azacitidine 32 durvalumab 31 130-nm albumin-bound paclitaxel 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07000110 2026-02-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡